Obtaining Normal Tissue Constraints Using Intensity Modulated Radiotherapy (IMRT) in Patients with Oral Cavity, Oropharnygeal, and Laryngeal Carcinoma

Braaksma, 2003, Optimisation of conformal radiation therapy by intensity modulation: Cancer of the larynx and salivary gland function, Radiother. Oncol, 66, 291, 10.1016/S0167-8140(03)00038-0 Chao, 2000, Intensity-modulated radiation therapy in head and neck cancers: The Mallinckrodt experience, Int. J. Cancer, 90, 92, 10.1002/(SICI)1097-0215(20000420)90:2<92::AID-IJC5>3.0.CO;2-9 Eisbruch, 2001, Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer, Int. J. Radiat. Oncol. Biol. Phys, 50, 695, 10.1016/S0360-3016(01)01512-7 Chao, 2002, Protection of salivary function by intensity-modulated radiation therapy in patients with head and neck cancer, Semin. Radiat. Oncol, 12, 20, 10.1053/srao.2002.31359 Eisbruch, 1999, Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer, Int. J. Radiat. Oncol. Biol. Phys, 45, 577, 10.1016/S0360-3016(99)00247-3 Parliament, 2004, Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head-and-neck cancer, Int. J. Radiat. Oncol. Biol. Phys, 58, 663, 10.1016/S0360-3016(03)01571-2 Roesink, 2005, A comparison of mean parotid gland dose with measures of parotid gland function after radiotherapy for head-and-neck cancer: Implications for future trials, Int. J. Radiat. Oncol. Biol. Phys, 63, 1006, 10.1016/j.ijrobp.2005.04.023 Munter, 2007, Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: Comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine, Int. J. Radiat. Oncol. Biol. Phys, 67, 651, 10.1016/j.ijrobp.2006.09.035 Hunt, 2006, Geometric factors influencing dosimetric sparing of the parotid glands using IMRT, Int. J. Radiat. Oncol. Biol. Phys, 66, 296, 10.1016/j.ijrobp.2006.05.028 Pedersen, 2002, Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion, Oral Dis, 8, 117, 10.1034/j.1601-0825.2002.02851.x Cooper, 1995, Late effects of radiation therapy in the head and neck region, Int. J. Radiat. Oncol. Biol. Phys, 31, 1141, 10.1016/0360-3016(94)00421-G Bussels, 2004, Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer, Radiother. Oncol, 73, 297, 10.1016/j.radonc.2004.09.015 Harrison, 1997, Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue, Head Neck, 19, 169, 10.1002/(SICI)1097-0347(199705)19:3<169::AID-HED1>3.0.CO;2-0 Porter, 2004, An update of the etiology and management of xerostomia, Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod, 97, 28, 10.1016/j.tripleo.2003.07.010 Johnson, 1993, Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer, N. Engl J. Med, 329, 390, 10.1056/NEJM199308053290603 Brizel, 2000, Phase III randomized trial of amifostine as a radioprotector in head and neck cancer, J. Clin. Oncol, 18, 3339, 10.1200/JCO.2000.18.19.3339 Antonadou, 2002, Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer, Int. J. Radiat. Oncol. Biol. Phys, 52, 739, 10.1016/S0360-3016(01)02683-9 Sasse, 2006, Amifostine reduces side effects and improves complete response rate during radiotherapy: Results of a meta-analysis, Int. J. Radiat. Oncol. Biol. Phys, 64, 784, 10.1016/j.ijrobp.2005.06.023 Buentzel, 2006, Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: A randomized placebo-controlled phase III study, Int. J. Radiat. Oncol. Biol. Phys, 64, 684, 10.1016/j.ijrobp.2005.08.005 Blanco, 2005, Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy, Int. J. Radiat. Oncol. Biol. Phys, 62, 1055, 10.1016/j.ijrobp.2004.12.076 Amosson, 2003, Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique, Int. J. Radiat. Oncol. Biol. Phys, 56, 136, 10.1016/S0360-3016(03)00093-2 Bjordal, 1994, Quality of life in patients treated for head and neck cancer: A follow-up study 7 to 11 years after radiotherapy, Int. J. Radiat. Oncol. Biol. Phys, 28, 847, 10.1016/0360-3016(94)90104-X Pow, 2006, Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial, Int. J. Radiat. Oncol. Biol. Phys, 66, 981, 10.1016/j.ijrobp.2006.06.013 Astreinidou, 2004, Level II lymph nodes and radiation-induced xerostomia, Int. J. Radiat. Oncol. Biol. Phys, 58, 124, 10.1016/S0360-3016(03)01391-9 Shah, 1993, Cervical lymph node metastasis, Curr. Probl. Surg, 30, 1, 10.1016/0011-3840(93)90012-6 Gregoire, 2000, Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy, Radiother. Oncol, 56, 135, 10.1016/S0167-8140(00)00202-4 Chao, 2005 Lee, 2002, Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience, Int. J. Radiat. Oncol. Biol. Phys, 53, 12, 10.1016/S0360-3016(02)02724-4 Chao, 2003, Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer, Int. J. Radiat. Oncol. Biol. Phys, 55, 312, 10.1016/S0360-3016(02)03940-8 Robar, 2007, Spatial and dosimetric variability of organs at risk in head-and-neck intensity modulated radiotherapy, Int. J. Radiat. Oncol. Biol. Phys., 68, 1121, 10.1016/j.ijrobp.2007.01.030 Manning, 2001, The effect of setup uncertainty on normal tissue sparing with IMRT for head-and-neck cancer, Int. J. Radiat. Oncol. Biol. Phys, 51, 1400, 10.1016/S0360-3016(01)01740-0 Siebers, 2005, Effect of patient setup errors on simultaneously integrated boost head and neck IMRT treatment plans, Int. J. Radiat. Oncol. Biol. Phys, 63, 422, 10.1016/j.ijrobp.2005.02.029